This Article Full Text (OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Krishnamurthy, S. Articles by Kreisel, F. PubMed PubMed Citation Articles by Krishnamurthy, S. Articles by Kreisel, F. Social Bookmarking                         What's this?

Pathologic and Clinical Features of Hodgkin Lymphoma–Like Posttransplant Lymphoproliferative Disease

^* To whom correspondence should be addressed. E-mail: kreiself{at}yahoo.com.

	Abstract

Because of its rarity, pathologic and clinical features of Hodgkin lymphoma–like posttransplant lymphoproliferative disorder (HL-like PTLD) are not well understood, and it is unclear whether its biological behavior is more closely related to classical Hodgkin disease or to monomorphic B-cell PTLD. The authors compared 6 cases of HL-like PTLD with 5 cases of monomorphic B-cell PTLD for differences in histology, immunophenotype, and clinical behavior. Histologically, all cases of HL-like PTLD resembled classical HL with typical Reed–Sternberg (RS) cells and a cellular background mimicking mixed cellularity subtype. CD45 was absent on RS-like cells, but the expression pattern of B-cellassociated markers Oct-2 and BOB.1 resembled monomorphic B-cell PTLD. Whereas Epstein–Barr virus early RNA expression is normally restricted to RS cells of classical HL, it was expressed in both RS-like cells and background lymphocytes in HL-like PTLD. Although all patients diagnosed with monomorphic B-cell PTLD show no evidence of disease following treatment, half of the patients with HL-like PTLD relapsed or died, indicating a more aggressive clinical behavior. The findings suggest that HL-like PTLD represents a distinct clinicopathologic entity with an aggressive clinical course.

First published on July 3, 2009
International Journal of Surgical Pathology 2009, doi:10.1177/1066896909338597


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?